TY - JOUR
T1 - Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells
AU - Zhang, Lei
AU - Cheng, Fangling
AU - Wei, Yiju
AU - Zhang, Lijun
AU - Guo, Dongsheng
AU - Wang, Baofeng
AU - Li, Wei
N1 - Funding Information:
Acknowledgements We thank Brian J. Lorah, Kim Powell, Bryan E. Achey and Steven P. Leibig in the Division of Health Physics, Yuka Imamura Kawasawa in the Institute for Personalized Medicine of Penn State College of Medicine for technical support. We thank Dong Kuang and Yan-Bing Chen in Department of Pathology of Tongji Hospital, Tongji Medical College, HUST for pathologic analysis. This work was supported by the National Natural Science Foundation of China 81472364 (to B.W.), the National Institutes of Health Grant K22 5K22CA190440 (to W.L.), the American Cancer Society-Institutional Research Grant 124171-IRG-13-043-01 (to W.L.), and the Four Diamonds Fund for Pediatric Cancer Research (to W.L.).
Publisher Copyright:
© 2018, Springer Nature Limited.
PY - 2019/4/11
Y1 - 2019/4/11
N2 - Glioblastoma (GBM) is the most aggressive brain tumor and resistant to current available therapeutics, such as radiation. To improve the clinical efficacy, it is important to understand the cellular mechanisms underlying tumor responses to radiation. Here, we investigated long-term cellular responses of human GBM cells to ionizing radiation. Comparing to the initial response within 12 hours, gene expression modulation at 7 days after radiation is markedly different. While genes related to cell cycle arrest and DNA damage responses are mostly modulated at the initial stage; immune-related genes are specifically affected as the long-term effect. This later response is associated with increased cellular senescence and inhibition of transcriptional coactivator with PDZ-binding motif (TAZ). Mechanistically, TAZ inhibition does not depend on the canonical Hippo pathway, but relies on enhanced degradation mediated by the β-catenin destruction complex in the Wnt pathway. We further showed that depletion of TAZ by RNAi promotes radiation-induced senescence and growth arrest. Pharmacological activation of the β-catenin destruction complex is able to promote radiation-induced TAZ inhibition and growth arrest in these tumor cells. The correlation between senescence and reduced expression of TAZ as well as β-catenin also occurs in human gliomas treated by radiation. Collectively, these findings suggested that inhibition of TAZ is involved in radiation-induced senescence and might benefit GBM radiotherapy.
AB - Glioblastoma (GBM) is the most aggressive brain tumor and resistant to current available therapeutics, such as radiation. To improve the clinical efficacy, it is important to understand the cellular mechanisms underlying tumor responses to radiation. Here, we investigated long-term cellular responses of human GBM cells to ionizing radiation. Comparing to the initial response within 12 hours, gene expression modulation at 7 days after radiation is markedly different. While genes related to cell cycle arrest and DNA damage responses are mostly modulated at the initial stage; immune-related genes are specifically affected as the long-term effect. This later response is associated with increased cellular senescence and inhibition of transcriptional coactivator with PDZ-binding motif (TAZ). Mechanistically, TAZ inhibition does not depend on the canonical Hippo pathway, but relies on enhanced degradation mediated by the β-catenin destruction complex in the Wnt pathway. We further showed that depletion of TAZ by RNAi promotes radiation-induced senescence and growth arrest. Pharmacological activation of the β-catenin destruction complex is able to promote radiation-induced TAZ inhibition and growth arrest in these tumor cells. The correlation between senescence and reduced expression of TAZ as well as β-catenin also occurs in human gliomas treated by radiation. Collectively, these findings suggested that inhibition of TAZ is involved in radiation-induced senescence and might benefit GBM radiotherapy.
UR - http://www.scopus.com/inward/record.url?scp=85058426174&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058426174&partnerID=8YFLogxK
U2 - 10.1038/s41388-018-0626-0
DO - 10.1038/s41388-018-0626-0
M3 - Article
C2 - 30542117
AN - SCOPUS:85058426174
SN - 0950-9232
VL - 38
SP - 2788
EP - 2799
JO - Oncogene
JF - Oncogene
IS - 15
ER -